Related Experiment Video
Updated: Jun 18, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
Mapping Atrial Fibrillation Drivers.
1The Department of Cardiovascular Medicine, Shin-Yurigaoka General Hospital, 215-0026 Kawasaki, Japan.
Reviews in Cardiovascular Medicine
|July 30, 2024
Summary
Pulmonary vein isolation effectively treats paroxysmal atrial fibrillation (AF). However, for persistent AF, identifying and targeting AF drivers through advanced mapping is crucial for developing effective ablation strategies.
Area of Science:
- Electrophysiology
- Cardiology
- Medical Technology
Background:
- Pulmonary veins initiate atrial fibrillation (AF).
- Pulmonary vein isolation (PVI) is effective for paroxysmal AF but less so for non-paroxysmal AF.
- Understanding AF maintenance mechanisms is vital for improved ablation strategies.
Purpose of the Study:
- To review current knowledge on atrial fibrillation (AF) drivers.
- To provide a comprehensive overview of mapping approaches for identifying AF drivers.
- To inform the development of advanced ablation strategies beyond PVI.
Main Methods:
- Review of existing literature on AF mechanisms and mapping technologies.
- Analysis of studies identifying focal or rotational drivers of AF in animal models and humans.
- Evaluation of new technologies for AF driver identification guiding catheter ablation.
Main Results:
- Focal or rotational drivers have been identified in AF.
- Advanced mapping technologies are emerging to pinpoint these drivers.
- These technologies serve as guides for catheter ablation procedures.
Conclusions:
- Current PVI strategies are insufficient for non-paroxysmal AF.
- Identifying and targeting AF drivers is essential for treating persistent AF.
- Advanced mapping techniques are critical for guiding new ablation strategies.
More Related Videos
Related Concept Videos
01:28Disturbances in Heart Rhythm
927
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
927
01:28Mechanism of Cardiac Arrhythmias
909
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
909
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
952
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
952
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
727
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
727
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413